2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole
| CAS No. | 475110-96-4 |
|---|---|
| MDL No. | MFCD08705334 |
| MF | C19H21F2N7O2 |
| MW | 417.40 |
| InChI Key | HGVNLRPZOWWDKD-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
ZSTK-474 is a triamino-1,3,5-triazine in which two hydrogens are replaced by morpholin-4-yl groups and one hydrogen is replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is a phosphatidylinositol 3-kinase inhibitor, acting as an EC 2.7.1.137 inhibitor and an antineoplastic agent. It belongs to morpholines, benzimidazoles, triamino-1,3,5-triazines, and organofluorine compounds.
| CAS No. | 475110-96-4 |
|---|---|
| Product Name | 2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole |
Biological Targets
PIK3R1·PIK3CB·PIK3CG·PIK3CA·PIK3R2·
Associated Conditions
neoplasm
* The information provided here is compiled from public sources and is for reference only.
